Rare diseases
Investigational molecules
Locations
Back to Poland337 clinical trials in Rzeszow, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa
PolandStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines
PolandStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
PolandStudy on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis
PolandStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
PolandStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
PolandStudy Comparing DB-1303 and Chemotherapy for Patients with HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
PolandStudy on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis
PolandStudy on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis
PolandStudy on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focusing on innovative treatments for inflammatory bowel diseases and autoimmune conditions, including studies on new therapies for ulcerative colitis and Crohn's disease.
Multiple trials evaluating novel compounds and biological therapies for inflammatory conditions.
Studies investigating treatments for heart failure prevention and metabolic disorders, with emphasis on innovative therapeutic approaches for obesity and cardiovascular health.
Focus on combination therapies and novel compounds for cardiometabolic conditions.
Clinical investigations targeting multiple sclerosis and chronic inflammatory conditions affecting the nervous system.
Evaluation of new therapeutic agents for managing neurological and immune-mediated conditions.
Research on various specialized conditions including geographic atrophy and reproductive health treatments.
Diverse studies focusing on improving patient outcomes across multiple therapeutic areas.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
